Table 3 Relationship of TREML4 mRNA expression with subclinical Atherosclerosis.

From: TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis

TREML4 mRNA expression

Control

SA

p-value

All (133)

All (207)

Non-expression

52.6 (70)

53.1 (110)

0.927

Expression

47.4 (63)

46.9 (97)

Low expression

50.8 (32)

49.5 (48)

0.871

High expression

49.2 (31)

50.5 (49)

  1. Number of subjects in parenthesis. Frequencies were compared by the Chi-Squared test. ‘SA’, subclinical Atherosclerosis; ‘Non-expression’, mRNA TREML4 not expressed; ‘Expression’, mRNA TREML4 expressed. ‘Low expression’, TREML4 mRNA expression below the median value; ‘High expression’, TREML4 mRNA expression above median value.